2012 annual financial data

Viridian Therapeutics 2012 Financial results

Direct answer

Revenue was 4.41M USD.

Operating income was -4.03M USD and net income was -7.21M USD.
Operating cash flow was -6.22M USD.

Get free Viridian Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
4.41M USD
Operating income
-4.03M USD
Net income
-7.21M USD
Operating cash flow
-6.22M USD